| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -9,480 | -114,470 | -960 | -560 | 0 |
| Net Income Growth | +91.72% | -11,823.97% | -71.43% | unch | unch |
Ocean Biomediacal Inc (OCEA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ocean Biomedical Inc. is a biopharma company which involved in development and commercialization of scientifically compelling assets. Its core portfolio is focused on oncology, pulmonary fibrosis and infectious disease. Ocean Biomedical Inc., formerly known as Aesther Healthcare Acquisitions Corp., is based in NEW YORK.
Fiscal Year End Date: 12/31